Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers?

Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers?

Bibliographic Details
Main Author:	Wilcock, G
Format:	Journal article
Language:	English
Published:	1994

Similar Items

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
by: Wilcock, G
Published: (1990)

Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease.
by: Forsyth, DR, et al.
Published: (1989)

Tacrine for Alzheimer's disease.
by: Qizilbash, N, et al.
Published: (2000)

Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.
by: Wilcock, G
Published: (1994)

Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease.
by: Roberts, C, et al.
Published: (1998)

Tacrine for senile dementia of Alzheimer's or Lewy body type.
by: Wilcock, G, et al.
Published: (1994)

Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease.
by: Ford, J, et al.
Published: (1993)

Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot study.
by: Forsyth, DR, et al.
Published: (1989)

Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
by: Qizilbash, N, et al.
Published: (1998)

Long-term use of tacrine
by: Wilcock, G, et al.
Published: (1994)

Long-term use of tacrine.
by: Wilcock, G, et al.
Published: (1994)

The presence of leuko-araiosis in patients with Alzheimer's disease predicts poor tolerance to tacrine, but does not discriminate responders from non-responders.
by: Amar, K, et al.
Published: (1997)

A double-blind, placebo-controlled study of tacrine in patients with Alzheimer's disease using SPET.
by: Prentice, N, et al.
Published: (1996)

PHARMACOKINETICS OF TACRINE HYDROCHLORIDE IN PATIENTS WITH DEMENTIA
by: Forsyth, D, et al.
Published: (1989)

Apolipoprotein E genotyping in Alzheimer's disease. The UK Alzheimer's Disease Genetic consortium.
by: Lovestone, S, et al.
Published: (1996)

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.
by: Kehoe, P, et al.
Published: (1996)

ADVANCES IN THE MANAGEMENT OF ALZHEIMERS-DISEASE - THE ROLE OF TACRINE - A SATELLITE SYMPOSIUM HELD DURING THE 6TH CONGRESS OF THE INTERNATIONAL-PSYCHOGERIATRIC-ASSOCIATION SEPTEMBER 8, 1993, BERLIN, GERMANY - INTRODUCTION AND OVERVIEW
by: Forette, F, et al.
Published: (1994)

INADEQUATE CARE FOR DEMENTIA SUFFERERS
by: Wilcock, G
Published: (1987)

Can blood concentrations of tacrine hydrochloride (THA) predict the risk of adverse effects?
by: Ford, J, et al.
Published: (1993)

Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000)

Neurotrophins in Alzheimer's disease
by: Wilcock, G
Published: (2002)

Hyperinsulinaemia and Alzheimer's disease.
by: Razay, G, et al.
Published: (1994)

Galantamine in Alzheimer's disease.
by: Razay, G, et al.
Published: (2008)

Age and Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1983)

Treating Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1995)

Velnacrine for Alzheimer's disease.
by: Birks, J, et al.
Published: (2004)

Alzheimer's disease--current issues.
by: Wilcock, G
Published: (1988)

Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee.
by: Wilcock, G, et al.
Published: (1989)

Why are drug trials in Alzheimer's disease failing?
by: Smith, A
Published: (2010)

Coping by the carers of dementia sufferers.
by: Saad, K, et al.
Published: (1995)

Treatment of the cholinergic impairment in Alzheimer's disease
by: Wilcock, G
Published: (1994)

Asymmetry of pathology in Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1987)

The olfactory bulbs in Alzheimer's disease.
by: Esiri, M, et al.
Published: (1984)

The increasing burden of Alzheimer disease.
by: Sadik, K, et al.
Published: (2003)

Current approaches to the treatment of Alzheimer's disease.
by: Wilcock, G
Published: (1996)

Bapineuzumab in Alzheimer's disease: where now?
by: Wilcock, G
Published: (2010)

Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK.
by: Dow, D, et al.
Published: (1999)

The metabolic syndrome and Alzheimer disease.
by: Razay, G, et al.
Published: (2007)

Associations of psychotic symptoms in dementia sufferers.
by: Ballard, C, et al.
Published: (1995)

THE ROLE OF GROWTH-FACTORS AND NEUROPEPTIDES IN ALZHEIMERS-DISEASE
by: Wilcock, G
Published: (1994)